|
Market Closed -
NYSE
07:00:02 31/10/26 am AEDT
|
5-day change | 1st Jan Change | ||
| 41.98 USD | -1.66% |
|
-8.12% | -55.97% |
| 31/10 | Rothschild & Co Redburn Adjusts Boston Scientific Price Target to $60 From $78 | MT |
| 30/10 | TD Cowen Downgrades Boston Scientific to Hold From Buy Price Target is $46 | MT |
| Market Cap | 60.84B 54.49B 50.12B 45.41B 84.89B 5,777B 86.48B 598B 240B 3,039B 228B 223B 9,583B | P/E 2026 * |
17x | P/E 2027 * | 18.5x |
|---|---|---|---|---|---|
| Enterprise Value | 72.3B 64.75B 59.56B 53.96B 101B 6,864B 103B 710B 285B 3,611B 271B 266B 11,387B | EV / Sales 2026 * |
3.45x | EV / Sales 2027 * | 3.3x |
| Free-Float |
82.47% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
NYSE
| BSX | Delayed | |
CBOE
| BSX | Real-time | |
|
Tradegate
| BSX | Real-time | |
|
Xetra
| BSX | Delayed | |
|
London S.E.
| 0HOY | Delayed | |
|
Boerse Muenchen
| BSX | Real-time | |
|
Mexican S.E.
| BSX * | End-of-day quote | |
|
Börse Stuttgart
| BSX | Delayed | |
|
CBOE
| Real-time | ||
|
Borsa Italiana
| 1BSX | End-of-day quote | |
|
Wiener Boerse
| BSXC | End-of-day quote | |
|
Deutsche Boerse AG
| BSX | Delayed | |
|
Swiss Exchange
| BSX | Delayed | |
|
Swiss Exchange
| BSX | Delayed | |
|
CBOE
| 0HOY | Real-time |
Last Transcript: Boston Scientific Corporation
| 1 day | -1.66% | ||
| 1 week | -8.12% | ||
| Current month | -3.83% | ||
| 1 month | -3.83% | ||
| 3 months | -8.74% | ||
| 6 months | -27.13% | ||
| Current year | -55.97% |
| 1 week | 39.57 |  | 46.07 |
| 1 month | 39.57 | | 46.16 |
| Current year | 39.57 | | 100.9 |
| 1 year | 39.57 | | 105.65 |
| 3 years | 39.57 | | 109.5 |
| 5 years | 34.98 | | 109.5 |
| 10 years | 19.67 | | 109.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
Michael Mahoney
CEO | Chief Executive Officer | 61 | 01/11/2011 |
Jonathan Monson
DFI | Director of Finance/CFO | 52 | 30/06/2025 |
Kenneth Stein
CTO | Chief Tech/Sci/R&D Officer | - | 01/09/2009 |
| Director | Title | Age | Since |
|---|---|---|---|
Michael Mahoney
CHM | Chairman | 61 | 03/05/2016 |
Edward Ludwig
BRD | Director/Board Member | 74 | 01/03/2014 |
Ellen Zane
BRD | Director/Board Member | 74 | 15/04/2016 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 25/8/26 | Buy | Director | 2,040 | 0.0001% | ||
| 11/8/26 | Other | Controller/Auditor | 2,930 | 0.0002% | ||
| 10/8/26 | Other | Chief Financial Officer | 9,908 | 0.0007% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.66% | -8.12% | -58.26% | -16.12% | 60.84B | |
| -1.72% | +3.44% | +25.31% | +60.56% | 258B | |
| -2.00% | +0.75% | +7.99% | +25.46% | 163B | |
| -3.73% | -4.48% | -18.49% | +67.13% | 150B | |
| -2.57% | +3.30% | +10.22% | +47.55% | 53.03B | |
| 0.00% | +2.46% | -11.97% | -6.29% | 53.31B | |
| -3.47% | +1.04% | +21.98% | +72.85% | 49.3B | |
| +0.84% | -3.12% | +9.80% | +64.47% | 50.67B | |
| -3.61% | +1.99% | +34.94% | +95.49% | 45.46B | |
| -18.64% | -12.41% | +138.35% | +118.77% | 35.63B | |
| Average | -3.66% | -1.52% | +15.99% | +52.99% | 91.91B | |
| Weighted average by Cap. | -2.74% | -0.34% | +10.35% | +50.55% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 20.96B 18.78B 17.27B 15.65B 29.25B 1,991B 29.8B 206B 82.68B 1,047B 78.68B 77.01B 3,302B | 21.03B 18.83B 17.32B 15.7B 29.34B 1,996B 29.89B 207B 82.92B 1,050B 78.91B 77.23B 3,312B |
| Net income | 3.59B 3.22B 2.96B 2.68B 5.01B 341B 5.1B 35.27B 14.16B 179B 13.47B 13.19B 566B | 3.33B 2.98B 2.74B 2.49B 4.65B 316B 4.73B 32.72B 13.13B 166B 12.5B 12.23B 525B |
| Net Debt | 11.46B 10.26B 9.44B 8.55B 15.98B 1,088B 16.28B 113B 45.18B 572B 42.99B 42.08B 1,805B | 8.52B 7.63B 7.02B 6.36B 11.89B 809B 12.12B 83.75B 33.62B 426B 31.99B 31.31B 1,343B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 30/10/26 | USD 41.98 | -1.66% | 22,467,158 |
| 29/10/26 | USD 42.69 | +0.61% | 31,755,378 |
| 28/10/26 | USD 42.43 | -5.84% | 69,837,060 |
| 27/10/26 | USD 45.06 | -1.14% | 15,139,721 |
| 26/10/26 | USD 45.58 | -0.24% | 11,928,715 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- BSX Stock
Select your edition
All financial news and data tailored to specific country editions
